Modulation of synaptogenesis
View Patent ↗Soluble proteins, e.g. Hevin, can trigger synapse formation; and other soluble proteins, e.g. SPARC antagonize this activity. Such proteins are synthesized in vitro and in vivo by astrocytes. Methods are provided for protecting or treating an individual suffering from adverse effects of deficits in synaptogenesis, or from undesirably active synaptogenesis.
1. A method of enhancing synaptogenesis in an individual with glaucoma comprising the step of:
contacting a retinal ganglion cell in an individual with glaucoma with an effective dose of a SEQ ID NO:1 polypeptide; wherein the number of synapses is increased in said retinal ganglion cell relative to a retinal ganglion cell that is not contacted with a SEQ ID NO:1 polypeptide.
2. The method of claim 1 , wherein the SEQ ID NO:1 polypeptide comprises residues 16-431 of SEQ ID NO:1.
3. The method of claim 1 , further comprising administration of neural progenitors.
4. The method of claim 1 , wherein the increased number of synapses is measured as a recovery of sensory abilities.